Cargando…
Challenges in generating costs and utilisation rates associated with castration-resistant prostate cancer
BACKGROUND: Prostate cancer (PCa), the most commonly diagnosed cancer among men in the United States and Europe, is an escalating resource allocation issue across healthcare systems in the Western world. The impact of skeletal-related events, associated with castration-resistant prostate cancer (CRP...
Autores principales: | Bourke, Siobhan, Burns, Richéal Maria, Gaynor, Caroline |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Co-Action Publishing
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865741/ https://www.ncbi.nlm.nih.gov/pubmed/27226831 http://dx.doi.org/10.3402/jmahp.v2.24072 |
Ejemplares similares
-
Treatment in the STAMPEDE era for castrate resistant prostate cancer in the UK: ongoing challenges and underappreciated clinical problems
por: Greasley, Rosa U., et al.
Publicado: (2018) -
Enzalutamide-resistant castration-resistant prostate cancer: challenges and solutions
por: Tucci, Marcello, et al.
Publicado: (2018) -
Nonmetastatic Castration-Resistant Prostate Cancer: Current Challenges and Trends
por: Figueiredo, Arnaldo, et al.
Publicado: (2022) -
Response Detection of Castrate-Resistant Prostate Cancer to Clinically Utilised and Novel Treatments by Monitoring Phospholipid Metabolism
por: Smith, Tim A. D., et al.
Publicado: (2017) -
Next Generation Sequencing in metastatic castrate-resistant prostate cancer
por: Adashek, Jacob J., et al.
Publicado: (2018)